Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-16-088486
Filing Date
2016-03-16
Accepted
2016-03-16 16:23:44
Documents
84
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v432195_10k.htm 10-K 1124793
2 EXHIBIT 10.96 v432195_ex10-96.htm EX-10.96 22359
3 EXHIBIT 21.1 v432195_ex21-1.htm EX-21.1 1647
4 EXHIBIT 31.1 v432195_ex31-1.htm EX-31.1 12243
5 EXHIBIT 32.1 v432195_ex32-1.htm EX-32.1 4854
  Complete submission text file 0001144204-16-088486.txt   8670507

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT prgb-20151231.xml EX-101.INS 1979335
7 XBRL TAXONOMY EXTENSION SCHEMA prgb-20151231.xsd EX-101.SCH 83387
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prgb-20151231_cal.xml EX-101.CAL 56174
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prgb-20151231_def.xml EX-101.DEF 522834
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE prgb-20151231_lab.xml EX-101.LAB 593909
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prgb-20151231_pre.xml EX-101.PRE 588230
Mailing Address 1311 PINEVIEW DRIVE SUITE 501 MORGANTOWN WV 26505
Business Address 1311 PINEVIEW DRIVE SUITE 501 MORGANTOWN WV 26505 304 292-2226
Protea Biosciences Group, Inc. (Filer) CIK: 0001335103 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51474 | Film No.: 161509982
SIC: 2834 Pharmaceutical Preparations